Charlotte Ungerth

CMO / Global Director Marketing & Strategy | Global Aesthetics, Longevity & Regenerative Medicine | P&L Leader | €500M Brand + US/China Launches | Pricing, Portfolio, AEO/GEO Omnichannel Growth

Florence, Tuscany, Italy

About

I’m a global leader with 25+ years in life sciences and medical devices, combining strategic portfolio thinking with premium brand building, team development to build strong modern omnichannel execution. My background spans over Global, European and Nordic leadership roles across developing teams and B2B/B2B2C business models working at the intersection of longevity, health, science, commercialization and human insight. I build growth by clarifying what a brand truly stands for, strengthening positioning, differentiation, and translating clinical credibility into clear communication, Building education concepts and clear launch excellence plans that teams can execute. I’m comfortable leading across the full commercial/marketing scope: digital authority, category strategy, portfolio and lifecycle planning, brand storytelling, customer education and KOL platforms - always in close partnership with crossfunctional teams. I’m particularly energized by environments where innovation, speed, quality and ambition meet: premium platforms and innovative life science businesses scaling across markets. I enjoy shaping teams, building structures that work seamlessly, and turning complexity into clarity, with high standards for both outcomes and culture. For the moment based in Europe with high flexibility for global travels

Experience

  • CMO/Global Medical Marketing Director at RELIFE Aesthetics
    Jan 2023 - Present · 3 yrs 7 mos

    Expanded company footprint into 20+ new international markets across EMEA, Middle East, and Asia, unlocking multimillion-euro revenue opportunities. • Launched first-in-class bio-active peptide . • Elevated brand to premium positioning, building B2B/B2C omnichannel strategy that increased digital HCP engagement +65% YoY and doubled lead generation. • Directed pipeline lifecycle management and acquisition strategies for longevity and regenerative medicine ensuring sustainable growth and competitive differentiation. Repositioned RELIFE to a pure play aesthetic company with the aim to redefine timeless beauty, strengthen multilayer combined technique educational concepts and launched first in class medical grade skincare by harnessing expert precision, progressive technology and Italian style - to make beauty timeless.

  • Galderma (7 yrs 9 mos)
    • Business Unit Director - Head of Aesthetics Business Unit Nordics
      Jan 2021 - Jan 2023 · 2 yrs 1 mo

      Full P&L responsibility for Nordic aesthetics business (Restylane, Dysport, Sculptra, new launches). Delivered +18% revenue growth YoY through new pricing model and portfolio optimization. Successfully launched 3 brands in 2 years, accelerating adoption and market share. Implemented global sales/marketing playbooks locally, achieving record profitability in 2022. • Evaluated and restructured team structure for 15 FTEs, meeting new organizational needs. Drove commercial excellence by aligning sales, marketing, and medical affairs functions to achieve record profitability

    • Head Of Global Marketing
      Oct 2018 - Jan 2021 · 2 yrs 4 mos

      Spearheaded strategy for +€500M Restylane Skinbooster Sculptra franchise transformation into iconic premium global brands. • Led first-in-market launches in US & China, expanding global footprint and revenue streams. • Developed digital tools adopted in 30+ countries, driving HCP/patient engagement and increasing consultation rates +25%. • Built & managed global KOL network (200+ injectors), securing scientific leadership and consistent brand messaging. Repositioned Sculptra and Skinboosters with new reconstitution protocol and signature injection techniques.

    • Head of Medical Device Portfolio EMEA/LATAM Global Strategic Marketing
      Jan 2018 - Oct 2018 · 10 mos

      As Strategic Head of EMEA and LATAM I headed the global Positioning, Packaging, Messaging, and Branding (PPMB) project from start to finish, ensuring successful completion of revamping the Galderma portfolio positioning, packaging, messaging and branding. Delivered the project on-time and within budget. Additionally, I provided effective assistance in creating Sculptra rebranding strategy to identify new business opportunities. Some of my contribution to the organisation includes: • Directed the execution of SKU rationalization decision from aesthetics SIG (Strategic Innovation Group). • Recognised and built the Restylane Megabrand defining the world broadest portfolio of HA fillers.

  • CEO and founder at HealthCare Innovations International
    Feb 2015 - Dec 2022 · 7 yrs 11 mos

    HealthCare Innovations offer a wide range of international customized consultancy services to meet your specific needs. Get direct access to the most effective support based on your project's current needs, lifecycle stage and your team's capabilities, goals and objectives. We focus on developing innovative brand strategies and global digital marketing initiatives within the healthcare segment.

  • Sobi - Swedish Orphan Biovitrum AB (publ) (4 yrs 7 mos)
    • Global Brand Director
      Nov 2010 - Oct 2014 · 4 yrs

      • Repositioned and relaunched Kineret, achieving +30% global sales growth. • Executed geographic expansion with 15 new distribution partners in Europe and LATAM. • Shaped value and communication strategies that unlocked new BD/licensing opportunities. Established LCM development plans as per R&D core team and global KOLs; obtained approval of plans by executive Project Management Committee (PMC). Along with that, I liaised with international thought leaders, such as NIH/NIAMS and PRINTO for the development of strategy for global publication plans. • Achieved strong market growth in highly competitive market through successful launch of two new ultra-rare orphan drug indications (NOMID/CAPS) for Kineret, using re-positioning strategies and successful implementation of global launch plans. • Arranged and implemented effective training and development programs for local teams and partners on strengthening our brand knowledge and solving strategic issues for smooth corporate implementation of new innovative e-learning platform. • Led and mentored cross-functional extended core team of 15-20 members, direct reports for a brand core team of eight, and led the international brand team of 18 medical/commercial FTEs

    • European Hematology Business Unit Director
      Apr 2010 - Nov 2010 · 8 mos

      • Lead representative in five co-promotion deals and business relationships. Overall responsible for profitable business development and value creation in people management. Securing Strategic Brand Management and fruitful Partner Liaisons.

  • Nordic Marketing & Sales Manager at Merck
    May 1995 - Dec 2007 · 12 yrs 8 mos

    Directed Nordic launch of JANUVIA, surpassing forecast by +20% in year one. • Designed multi-channel campaigns that doubled physician engagement and set new benchmarks for MSD Nordics. • Held senior external affairs role, leading innovative market access strategies across Europe.